{"filing":{"accession_number":"0001575872-26-000724","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"rdy0953_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000724/rdy0953_6k.htm"},"events":[{"id":37542,"run_id":34601,"accession_number":"0001575872-26-000724","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The disclosure announces the Board-approved appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026, with induction into the Management Council. Although Ravi is a related party (son-in-law of Co-Chairman G V Prasad), the appointment to a senior management role overseeing a major business unit (Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary) is a material executive appointment that would affect investor assessment of leadership and governance.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-10-23","form":"6-K","submitted_at":null,"items":[{"id":42287,"accession_number":"0001575872-26-000724","item_number":"EX-99.1","item_title":"rdy0953_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces the Board-approved appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026, with induction into the Management Council. Although Ravi is a related party (son-in-law of Co-Chairman G V Prasad), the appointment to a senior management role overseeing a major business unit (Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary) is a material executive appointment that would affect investor assessment of leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T18:17:37.609104+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42287,"accession_number":"0001575872-26-000724","item_number":"EX-99.1","item_title":"rdy0953_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces the Board-approved appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026, with induction into the Management Council. Although Ravi is a related party (son-in-law of Co-Chairman G V Prasad), the appointment to a senior management role overseeing a major business unit (Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary) is a material executive appointment that would affect investor assessment of leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T18:17:37.609104+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-10-23"}]}